JP2024504645A5 - - Google Patents
Info
- Publication number
- JP2024504645A5 JP2024504645A5 JP2023542925A JP2023542925A JP2024504645A5 JP 2024504645 A5 JP2024504645 A5 JP 2024504645A5 JP 2023542925 A JP2023542925 A JP 2023542925A JP 2023542925 A JP2023542925 A JP 2023542925A JP 2024504645 A5 JP2024504645 A5 JP 2024504645A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- pterostilbene
- silibinin
- disease
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382036.8A EP4029496A1 (en) | 2021-01-18 | 2021-01-18 | Pterostilbene and silibinin for preventing, ameliorating or reducing radiation-induced diseases |
| EP21382036.8 | 2021-01-18 | ||
| PCT/EP2022/051038 WO2022152943A1 (en) | 2021-01-18 | 2022-01-18 | Pterostilbene and silibinin for preventing, ameliorating or reducing radiation-induced diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504645A JP2024504645A (ja) | 2024-02-01 |
| JP2024504645A5 true JP2024504645A5 (enExample) | 2025-01-28 |
Family
ID=74205784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542925A Pending JP2024504645A (ja) | 2021-01-18 | 2022-01-18 | 放射線誘発性疾患を予防、改善、又は軽減するプテロスチルベン及びシリビニン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250275940A1 (enExample) |
| EP (2) | EP4029496A1 (enExample) |
| JP (1) | JP2024504645A (enExample) |
| KR (1) | KR20230135110A (enExample) |
| CN (1) | CN117202900A (enExample) |
| AU (1) | AU2022207675A1 (enExample) |
| CA (1) | CA3207734A1 (enExample) |
| ES (1) | ES3029832T3 (enExample) |
| MX (1) | MX2023008447A (enExample) |
| PL (1) | PL4277610T3 (enExample) |
| WO (1) | WO2022152943A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115969741B (zh) * | 2023-02-21 | 2025-02-11 | 水羊化妆品制造有限公司 | 小花茉莉花蜡和/或小花茉莉净油组合物及应用 |
| JP7799975B2 (ja) * | 2023-03-29 | 2026-01-16 | 株式会社大阪ソーダ | 皮膚バリヤ機能改善剤、及び肌状態改善剤 |
| EP4541351A1 (en) * | 2023-10-18 | 2025-04-23 | Center for Intelligent Research in Crystal Engineering, S.L. | Compounds and combination as stimulators of collagen synthesis |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3926711B2 (ja) * | 2002-08-30 | 2007-06-06 | 株式会社ファンケル | 表皮の偏平化を予防、防止、改善する皮膚老化防止用組成物 |
| JP2006265186A (ja) * | 2005-03-24 | 2006-10-05 | Fancl Corp | シリマリン含有光老化防止剤キット |
| US9050284B2 (en) * | 2009-02-09 | 2015-06-09 | Sami Labs Limited | Orally bioavailable stilbenoids—compositions and therapeutic applications thereof |
| US20110136751A1 (en) * | 2009-10-06 | 2011-06-09 | Green Molecular | Use of Polyphenols in the Treatment of Cancer |
| FR2961814B1 (fr) * | 2010-06-29 | 2014-09-26 | Isp Investments Inc | Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant. |
| MX2014003606A (es) * | 2011-09-27 | 2015-01-16 | Univ Virginia Commonwealth | Enfoque metabolico selectivo para aumentar la biodisponibilidad oral de la fenilefrina y otros bioactivos metabolicos. |
| WO2014112194A1 (ja) * | 2013-01-21 | 2014-07-24 | 富士フイルム株式会社 | 油性組成物、並びにそれを含むエマルション組成物及び皮膚外用組成物 |
| WO2014151891A1 (en) * | 2013-03-14 | 2014-09-25 | Walley Darlene | Topical products |
| WO2014168925A1 (en) * | 2013-04-08 | 2014-10-16 | Virginia Commonwealth University | Compositions to alleviate presystemic metabolism of opioids |
| MX394291B (es) * | 2013-10-30 | 2025-03-24 | Chromadex Inc | Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel. |
| KR20170045343A (ko) * | 2014-09-04 | 2017-04-26 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부의 장벽 기능의 ｕｖ-유도 상실을 치료하는데 사용하기 위한 국소 프테로스틸벤 조성물 |
| CA3021022C (en) * | 2016-04-14 | 2024-04-23 | ChromaDex Inc. | Use of nicotinamide riboside, nicotinic acid riboside, nicotinamide mononucleotide, and nicotinoyl compound derivatives in infant formula |
| BR112019003579A2 (pt) * | 2016-08-22 | 2019-05-21 | Elysium Health, Inc. | Composições de ribosídeo de nicotinamida e pterostilbeno e métodos para o tratamento dedistúrbios neurodegenerativos |
| CN109419634B (zh) * | 2017-08-31 | 2023-01-31 | 富士胶片株式会社 | 水包油型乳化组合物以及皮肤外用剂 |
| CN108478479A (zh) * | 2018-04-02 | 2018-09-04 | 青岛科技大学 | 含有能自行提供弱酸性环境的紫檀芪复合物的眼部抗皱啫喱及其制备方法 |
-
2021
- 2021-01-18 EP EP21382036.8A patent/EP4029496A1/en not_active Withdrawn
-
2022
- 2022-01-18 ES ES22701924T patent/ES3029832T3/es active Active
- 2022-01-18 PL PL22701924.7T patent/PL4277610T3/pl unknown
- 2022-01-18 AU AU2022207675A patent/AU2022207675A1/en active Pending
- 2022-01-18 KR KR1020237028032A patent/KR20230135110A/ko active Pending
- 2022-01-18 WO PCT/EP2022/051038 patent/WO2022152943A1/en not_active Ceased
- 2022-01-18 EP EP22701924.7A patent/EP4277610B1/en active Active
- 2022-01-18 JP JP2023542925A patent/JP2024504645A/ja active Pending
- 2022-01-18 CN CN202280022392.4A patent/CN117202900A/zh active Pending
- 2022-01-18 MX MX2023008447A patent/MX2023008447A/es unknown
- 2022-01-18 CA CA3207734A patent/CA3207734A1/en active Pending
- 2022-01-18 US US18/271,184 patent/US20250275940A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Targum et al. | Fenfluramine provocation of anxiety in patients with panic disorder | |
| EP1622579B1 (en) | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin | |
| US6524623B1 (en) | Therapeutic compositions and methods of use thereof | |
| JP7727543B2 (ja) | ホスホジエステラーゼ阻害剤を含有する放出調節錠剤製剤 | |
| ES3057870T3 (en) | Induced expression of brain derived neurotrophic factor (bdnf) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases | |
| CN103432244A (zh) | 一种具有祛痘功能的组合物 | |
| CN113893240A (zh) | 包含15-hepe的组合物和其使用方法 | |
| JP6185773B2 (ja) | 医薬組成物 | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| JPH0635387B2 (ja) | 光防御剤 | |
| Brazzelli et al. | Non-Invasive Evaluation of Tacalcitol Plus Puva versus Tacalcitol Plus UVB-NB in the Treatment of Psoriasis:“Right-Left Intra-Individual—Pre/Post Comparison Design” | |
| AU2020282051B2 (en) | Composition containing fluoxetine and vitamin D 3 or its derivatives and application thereof | |
| JP3207996B2 (ja) | 日焼け止め化粧料 | |
| AU2001287706B2 (en) | Treatment of burns | |
| El-Mofty et al. | Phototherapy in vitiligo: a comparative evaluation of various therapeutic modalities | |
| US5942247A (en) | Method for treating pediatric high grade astrocytoma including brain stem glioma | |
| Hirata et al. | Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositis | |
| Dantas et al. | Cryotherapy short-term use relieves pain, improves function and quality of life in individuals with knee osteoarthritis–randomized controlled trial | |
| CN110652537A (zh) | 一种用于治疗面部色斑的外敷制剂 | |
| EP3206694B1 (en) | Use of neridronic acid or of its salt for the treatment of osteoarthrosis | |
| CN102949567A (zh) | 一种用于祛黄褐斑的药物胶囊及其制备方法 | |
| Gonzalez-Lopez et al. | Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis | |
| JP2017190346A (ja) | 医薬組成物 | |
| US20110301115A1 (en) | Methods of Treating Subclinical Sun Damage | |
| Bakhshi et al. | Clinical Study Combination Therapy with 1% Nanocurcumin Gel and 0.1% Triamcinolone Acetonide Mouth Rinse for Oral Lichen Planus: A Randomized Double-Blind Placebo Controlled Clinical Trial |